YHB Investment Advisors Inc. maintained its stake in shares of Aetna Inc. (NYSE:AET) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,095 shares of the company’s stock at the end of the second quarter. YHB Investment Advisors Inc.’s holdings in Aetna were worth $318,000 as of its most recent filing with the SEC.
A number of other large investors also recently made changes to their positions in the company. Foster & Motley Inc. raised its position in Aetna by 2.5% in the second quarter. Foster & Motley Inc. now owns 10,501 shares of the company’s stock worth $1,594,000 after buying an additional 259 shares in the last quarter. Barry Investment Advisors LLC increased its stake in shares of Aetna by 14.1% in the second quarter. Barry Investment Advisors LLC now owns 2,113 shares of the company’s stock valued at $321,000 after buying an additional 261 shares during the last quarter. River Wealth Advisors LLC increased its stake in shares of Aetna by 8.6% in the second quarter. River Wealth Advisors LLC now owns 6,722 shares of the company’s stock valued at $1,021,000 after buying an additional 532 shares during the last quarter. Daiwa Securities Group Inc. increased its stake in shares of Aetna by 326.0% in the second quarter. Daiwa Securities Group Inc. now owns 50,580 shares of the company’s stock valued at $7,679,000 after buying an additional 38,706 shares during the last quarter. Finally, Bessemer Group Inc. increased its stake in shares of Aetna by 0.9% in the second quarter. Bessemer Group Inc. now owns 14,962 shares of the company’s stock valued at $2,272,000 after buying an additional 140 shares during the last quarter. Hedge funds and other institutional investors own 91.69% of the company’s stock.
Aetna Inc. (NYSE AET) traded down 0.87% during trading on Friday, hitting $154.45. 1,781,161 shares of the stock traded hands. The firm’s 50-day moving average is $154.81 and its 200 day moving average is $140.38. Aetna Inc. has a 52 week low of $104.59 and a 52 week high of $161.69. The stock has a market cap of $51.29 billion, a P/E ratio of 34.28 and a beta of 0.54.
Aetna (NYSE:AET) last issued its earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.34 by $1.08. The business had revenue of $15.52 billion during the quarter, compared to the consensus estimate of $15.34 billion. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The firm’s revenue for the quarter was down 2.7% on a year-over-year basis. During the same period in the previous year, the company posted $2.21 earnings per share. Equities research analysts forecast that Aetna Inc. will post $9.55 earnings per share for the current fiscal year.
WARNING: This piece of content was reported by BNB Daily and is owned by of BNB Daily. If you are reading this piece of content on another website, it was stolen and reposted in violation of United States and international copyright & trademark laws. The correct version of this piece of content can be read at https://www.baseball-news-blog.com/2017/08/19/yhb-investment-advisors-inc-has-318000-stake-in-aetna-inc-nyseaet-updated.html.
AET has been the topic of a number of research analyst reports. Deutsche Bank AG upped their price target on shares of Aetna from $144.00 to $157.00 and gave the company a “hold” rating in a report on Thursday, July 13th. Credit Suisse Group reissued a “buy” rating and issued a $155.00 price objective on shares of Aetna in a research report on Wednesday, May 17th. Cowen and Company set a $170.00 price objective on shares of Aetna and gave the company a “buy” rating in a research report on Saturday, May 27th. Jefferies Group LLC reaffirmed a “hold” rating and set a $163.00 price target (up previously from $157.00) on shares of Aetna in a research report on Friday, August 4th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $175.00 price target (up previously from $150.00) on shares of Aetna in a research report on Wednesday, August 9th. Seven equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. Aetna currently has an average rating of “Buy” and a consensus price target of $157.99.
In other Aetna news, EVP Margaret M. Mccarthy sold 27,028 shares of Aetna stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total value of $4,033,388.44. Following the completion of the sale, the executive vice president now directly owns 33,563 shares in the company, valued at $5,008,606.49. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 0.90% of the company’s stock.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.